来自北京的A股上市公司南华期货(603093.SH)于周五(11月22日)发布公告，公布公司申请香港上市的进展，香港联交所上 市委员会于2025年11月20日举行上市聆讯，审议公司本次发行上市的申请。 公司本次发行上市的独家保荐人已于2025年11月21日收到香港联交所向其发出的信函，其中指出香港联交所上市委员会已 审阅公司的上市申请，但该信函不构成正式的上市批准，香港联交所仍有对公司的上市申请提出进一步意见的权力。公司 本次发行上市尚需取得香港证券及期货事务监察委员会和香港联交所等相关监管机构、证券交易所的最终批准，该事项仍 存在不确定性。 南华期货，于2025年4月17日、10月31日先后两次在港交所递交招股书；后于9月19日收到中国证监会境外发行上市备案通 知书，可发行不超过1.55亿股境外上市普通股并在香港联合交易所上市。 南华期货，作为中国领先的期货公司，为客户提供全球金融服务，产品服务包括中国境内期货经纪、中国境内风险管理服 务、中国境内财富管理以及境外金融服务。 来源：瑞恩资本RyanbenCapital 南华期货招股书链接： https://www1.hkexnews.hk/app/sehk/ ...

Group 1: Recent IPOs - Minglue Technology, a data intelligence application software company, successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 1.018 billion with a market capitalization of HKD 31.301 billion [1] - Seres, a new energy vehicle brand, completed its IPO on the Hong Kong Stock Exchange, raising around HKD 14.283 billion and achieving a market capitalization of HKD 247.6 billion [2] - Joyson Electronics, a provider of automotive technology solutions, successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 3.412 billion with a market capitalization of HKD 31.388 billion [3] - Wangshan Wangshui, a biopharmaceutical company, completed its IPO on the Hong Kong Stock Exchange, raising about HKD 0.587 billion and achieving a market capitalization of HKD 13.743 billion [4] - WeRide, an L4 autonomous driving technology company, successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 2.392 billion with a market capitalization of HKD 25.049 billion [5] Group 2: Companies Filing for IPO - Xinde Semiconductor, a semiconductor packaging and testing solutions provider, filed for an IPO on the Hong Kong Stock Exchange [6] - Haiguangxin, a provider of optical interconnect products, submitted an IPO application to the Hong Kong Stock Exchange, ranking 10th globally in professional optical module providers by revenue for 2024 [8] - Dingtai Pharmaceutical, a contract research organization, filed for an IPO on the Hong Kong Stock Exchange, offering integrated solutions for pharmaceutical companies and research institutions [9] - Haote Energy, an energy management solutions provider, submitted an IPO application to the Hong Kong Stock Exchange, focusing on data center energy management [10] - Guoxia Technology, a renewable energy solutions provider, filed for an IPO on the Hong Kong Stock Exchange, specializing in energy storage systems [11] - Tiantong Vision, an L4 solution provider, submitted an IPO application to the Hong Kong Stock Exchange, offering comprehensive intelligent driving solutions [12] - Lupeng Pharmaceutical, a platform-based pharmaceutical company, filed for an IPO on the Hong Kong Stock Exchange, focusing on high bioavailability oral drugs [13][14] - Libang Pharmaceutical, a biopharmaceutical company specializing in kidney disease, submitted an IPO application to the Hong Kong Stock Exchange [15] - FSTech, a provider of electric drive solutions, filed for an IPO on the Hong Kong Stock Exchange, ranking second in China's industrial control sector by revenue for 2024 [16] - Ketao Co., a smart parking space operator, refiled for an IPO on the Hong Kong Stock Exchange after a previous application expired [17] - Zhihui Interconnect, an AI company, submitted an IPO application to the Hong Kong Stock Exchange, focusing on urban traffic management solutions [18] - Taotao Vehicle, an electric mobility company, filed for an IPO on the Hong Kong Stock Exchange, ranking second globally in the electric low-speed vehicle industry by revenue for 2024 [19] - Nanhua Futures, a financial services provider, refiled for an IPO on the Hong Kong Stock Exchange after a previous application expired [20] Group 3: Companies Passing Hearings - Haiwei Electronics, a capacitor film manufacturer, passed the listing hearing on the Hong Kong Stock Exchange, ranking second in China by capacitor film sales volume for 2024 [21] Group 4: Companies Approved for Filing - Xidi Zhijia received approval for overseas issuance and "full circulation" of unlisted shares from the China Securities Regulatory Commission [22]

根据备案通知书，南华期货拟发行不超过约1.55亿股股境外上市普通股并在香港联合交易所上市。 来源：瑞恩资本 2025年9月19日，中国证监会国际合作司发布关于南华期货股份有限公司(以下简称南华期货)境外发行 上市备案通知书(国合函[2025]1618号)。 南华期货招股书链接： https://www1.hkexnews.hk/app/sehk/2025/107301/documents/sehk25041702069_c.pdf 南华期货(603093.SH)，于2019年8月30日在A股上市，为中国首家在A股上市的期货公司，截至周一 (2025年9月22日)收市，总市值约人民币131亿元。 南华期货，于2025年4月17日在港交所递交招股书，中信证券独家保荐。 南华期货，成立于1996年，作为一家综合性的全球金融服务平台，产品服务包括中国境内期货经纪、中 国境内风险管理服务、中国境内财富管理以及境外金融服务，涵盖了期货及衍生品的整个价值链。根据 弗若斯特沙利文报告，在中国：按2023年总收入计，南华期货在所有期货公司中排名第8，在所有非金 融机构相关期货公司中排名第1；按2023年期货经纪佣金收入计，其在 ...